Prevention and Transplantation in Chronic Kidney Disease: What Is Achievable in Emerging Countries?

被引：7

作者：

Persy, Veerle P. ^{[1
]}

Remuzzi, Giuseppe ^{[2
]}

Perico, Norberto ^{[2
]}

Gharbi, Mohammed Benghanem ^{[3
]}

Adu, Dwomoa ^{[4
]}

Jha, Vivekanand ^{[5
]}

Rizvi, Adib ^{[6
]}

Ben Ammar, Mohamed ^{[7
]}

Fongoro, Sahare ^{[8
]}

De Broe, Marc E. ^{[9
]}

机构：

[1] Hugin Mugin Res, Antwerp, Belgium

[2] Mario Negri Inst Pharmacol Res, I-24100 Bergamo, Italy

[3] Univ Casablanca, Casablanca, Morocco

[4] Univ Hosp Birmingham, Birmingham, W Midlands, England

[5] Postgrad Med Inst, Chandigarh, India

[6] Sindh Inst Urol & Transplantat, Karachi, Pakistan

[7] CHU Mongi Slim, La Marsa, Tunisia

[8] Univ Hosp Point G, Bamako, Mali

[9] Univ Antwerp, Dept Pathophysiol, BE-2610 Antwerp, Belgium

来源：

NEPHRON CLINICAL PRACTICE | 2010年 / 115卷 / 02期

关键词：

CKD; prevention and transplantation; emerging countries; Renal disease; screening and prevention; ESRD treatment; Transplantation programs in Africa; LOW-DOSE KETOCONAZOLE; MYCOPHENOLATE-MOFETIL; INDUCTION THERAPY; FOLLOW-UP; RENAL-TRANSPLANTATION; IMMUNOSUPPRESSIVE REGIMENS; CYCLOSPORINE WITHDRAWAL; ACUTE REJECTION; RECIPIENTS; AZATHIOPRINE;

D O I：

10.1159/000312875

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Experts from all continents discussed the present and future of nephrology and transplantation medicine in emerging countries during a 3-day conference, supported by the World Health Organization, the International Society of Nephrology, the Transplantation Society - Global Alliance for Transplantation and the Ministry of Health of the Republic of Mali. This conference was held in Bamako, Mali on December 4-6, 2008, and focused on prevention and treatment of chronic kidney disease in emerging countries. Apart from delivering high-quality medical and scientific knowledge, the meeting was mainly a call to action for emerging countries to start chronic kidney disease prevention and screening programs, develop end-stage renal disease registries and start or further elaborate transplantation programs. International as well as regional collaborations need to be stimulated and strengthened in order to allow emerging countries to acquire the information, technology, experience and skills necessary to achieve these ambitious goals. Copyright (C) 2010 S. Karger AG, Basel

引用

页码：C122 / C132

页数：11

共 50 条

[41] Current and emerging treatment options for the elderly patient with chronic kidney disease
Fassett, Robert G.
CLINICAL INTERVENTIONS IN AGING, 2014, 9 : 191 - 199
[42] The emerging pillars of chronic kidney disease: no longer a bystander in metabolic medicine
Wonnacott, Alexa
CLINICAL MEDICINE, 2023, 23 (03) : 254 - 258
[43] Surgical prevention and management of vascular complications of kidney transplantation
Bessede, Thomas
Droupy, Stephane
Hammoudi, Yacine
Bedretdinova, Dina
Durrbach, Antoine
Charpentier, Bernard
Benoit, Gerard
TRANSPLANT INTERNATIONAL, 2012, 25 (09) : 994 - 1001
[44] Evidence for a role of uromodulin in chronic kidney disease progression
Prajczer, Sinikka
Heidenreich, Ursula
Pfaller, Walter
Kotanko, Peter
Lhotta, Karl
Jennings, Paul
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (06) : 1896 - 1903
[45] What is Polypharmacy in Patients with Chronic Kidney Disease? A Systematic Review
Al-Khulaifi, Azhar
Khatib, Malkan
Ali, Elrazi
Ali, Mohamed Yousif
Danjuma, Mohammed Ibn-Mas'ud
CLINICAL THERAPEUTICS, 2023, 45 (11) : E217 - E221
[46] Blood pressure goal in chronic kidney disease: what is the evidence?
Agarwal, Rajiv
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2011, 20 (03) : 229 - 232
[47] Chronic kidney disease, diabetes, and hypertension: what's in a name?
Levey, Andrew S.
Astor, Brad C.
Stevens, Lesley A.
Coresh, Josef
KIDNEY INTERNATIONAL, 2010, 78 (01) : 19 - 22
[48] What is confirmed in the treatment of metabolic acidosis in chronic kidney disease?
Ritter, Alexander
Kuhn, Christian
Mohebbi, Nilufar
INNERE MEDIZIN, 2024, : 1209 - 1215
[49] Is the dietary protein restriction achievable in chronic kidney disease? The impact upon quality of life and the dialysis delay
Koulouridis, E.
Koulouridis, I
HIPPOKRATIA, 2011, 15 : 3 - 7
[50] Chronic kidney disease. What is currently available for treatment?
Fleig, S.
Patecki, M.
Schmitt, R.
INTERNIST, 2016, 57 (12): : 1164 - 1171

← 1 2 3 4 5 →